Creatine monohydrate
The most studied and effective ergogenic supplement there is.
What it is for
Strength, power and hypertrophy; possible cognitive and recovery support.
How it works
It increases muscle phosphocreatine stores, regenerating ATP faster in short, intense efforts. It enables more quality reps and a slight intracellular water retention that favours anabolic signalling.
Dosing
3–5 g/day consistently. An optional loading phase (20 g/day split over 5–7 days) saturates you sooner.
When to take it
Any time; daily consistency matters more than the hour. Monohydrate is the most studied, cheapest and most effective form.
Safety
Very safe long term in healthy people. It does not damage the kidneys or liver in healthy subjects (a myth debunked in the literature).
Side effects
A slight weight increase from water (1–2 kg). Digestive discomfort if you take high doses at once (avoid this by splitting them).
Interactions
No relevant interactions with caffeine in practice (the supposed conflict is minor and disputed).
Contraindications
Caution with pre-existing kidney disease: consult your doctor.
Who it has been studied in
Benefits in young people, older adults (mass and function), vegetarians (a greater response) and possible cognitive support during sleep deprivation.
Frequently asked
Do I need a loading phase?
No. It only brings saturation forward by a few days; 3–5 g/day reach the same point in ~3–4 weeks.
Do I need to cycle it?
No need. It is safe taken continuously.
Does it break a fast?
It provides no meaningful calories and does not significantly raise insulin.
What this rests on
International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine
Kreider RB, Kalman DS, Antonio J, et al. · 2017 · Journal of the International Society of Sports Nutrition
Effect: Descrita como el suplemento ergogénico legal más eficaz disponible para el entrenamiento de fuerza, con mejoras consistentes frente a placebo en la mayoría de los estudios sintetizados.
Limitations: Es una postura de consenso sobre cientos de estudios, no un metaanálisis único con un tamaño de efecto agregado; la respuesta individual varía ('respondedores' frente a 'no respondedores').
- Evidence tier
- A
- Quality
- High (many RCTs and meta-analyses)
- Studies
- >500 human studies
- Consensus
- ISSN position in favour; strong consensus
- Controversy
- 'New' forms (HCl, kre-alkalyn) do not beat monohydrate
- Reviewed
- 2024
Strength of evidence out of 5.